TINF2 and cancer: Cancer is more common in people with TBDs; around 1%–4% of patients with TINF2 mutations have cancer, which tends to affect tissues with rapid turnover (skin, mucus membranes, and bone marrow) (Alter et al., 2009; Vulliamy et al., 2011).